These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin. Kubin A; Meissner P; Wierrani F; Burner U; Bodenteich A; Pytel A; Schmeller N Photochem Photobiol; 2008; 84(6):1560-3. PubMed ID: 18627521 [TBL] [Abstract][Full Text] [Related]
3. [Fluorescence diagnosis and photodynamic therapy in urology]. Stepp H; Waidelich R Aktuelle Urol; 2007 Nov; 38(6):455-64. PubMed ID: 17987533 [TBL] [Abstract][Full Text] [Related]
4. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Cauberg EC; de Bruin DM; Faber DJ; van Leeuwen TG; de la Rosette JJ; de Reijke TM Eur Urol; 2009 Aug; 56(2):287-96. PubMed ID: 19285787 [TBL] [Abstract][Full Text] [Related]
5. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic diagnosis in urology: state of the art. Santos Cortes JA; Gahan J; Soloway MS Arch Esp Urol; 2011; 64(1):18-31. PubMed ID: 21289382 [TBL] [Abstract][Full Text] [Related]
7. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. Zaak D; Karl A; Knüchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C BJU Int; 2005 Aug; 96(2):217-22. PubMed ID: 16001963 [TBL] [Abstract][Full Text] [Related]
9. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Witjes JA; Douglass J Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969 [TBL] [Abstract][Full Text] [Related]
10. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ; J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291 [TBL] [Abstract][Full Text] [Related]
11. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence cystoscopy: is it ready for use in routine clinical practice? Spiess PE; Grossman HB Curr Opin Urol; 2006 Sep; 16(5):372-6. PubMed ID: 16905985 [TBL] [Abstract][Full Text] [Related]
13. Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis. Tritschler S; Scharf S; Karl A; Tilki D; Knuechel R; Hartmann A; Stief CG; Zaak D Eur Urol; 2007 Feb; 51(2):403-7; discussion 407-8. PubMed ID: 16939699 [TBL] [Abstract][Full Text] [Related]